Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.

37,448
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,872
Class I recallsReasonable probability of serious health consequences
24,509
Class II recallsTemporary or medically reversible health consequences
2,932
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,096 recalls
Most affected stateHawaii 200 recalls mention this state

Advertisement

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,956 recalls have been announced year to date.
  • Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
  • The highest complete period was Jun 2026 (300).
  • Nov 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,509
Class I9,872
Class III2,932
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,509
Class I9,872
Class III2,932
Not Yet Classified2

Showing 6,041–6,060 of 18,373 recalls

FDA Recall TerminatedTerminated: December 6, 2023Historical recordClass II

dilTIAZem HCl in 5% Dextrose Injection, 125 mg per 125 mL, (32 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-951-01.

by SterRx, LLC

Reason
Lack of Assurance of Sterility
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 6, 2023Historical recordClass II

NOREPINEPHRINE in 5% Dextrose Injection, 8 mg per 250 mL (32 mg per mL) Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-476-01.

by SterRx, LLC

Reason
Lack of Assurance of Sterility
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 6, 2023Historical recordClass II

Morphine Sulfate in 5% Dextrose Injection, 100 mg per 100 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-452-01.

by SterRx, LLC

Reason
Lack of Assurance of Sterility
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 6, 2023Historical recordClass II

Midazolam in 0.9% Sodium Chloride Injection, 100 mg per 100 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-102-02.

by SterRx, LLC

Reason
Lack of Assurance of Sterility
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 6, 2023Historical recordClass II

EPINEPHrine in 0.9% Sodium Chloride Injection, 16 mg per 250 mL (64 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-627-01.

by SterRx, LLC

Reason
Lack of Assurance of Sterility
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 6, 2023Historical recordClass II

EPINEPHIrine in 0.9% Sodium Chloride Injection, 8 mg per 250 mL (32 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-077-01.

by SterRx, LLC

Reason
Lack of Assurance of Sterility
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 6, 2023Historical recordClass II

EPINEPHIrine in 0.9% Sodium Chloride Injection, 5 mg per 250 mL (20 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-052-01.

by SterRx, LLC

Reason
Lack of Assurance of Sterility
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 6, 2023Historical recordClass II

EPINEPHIrine in 0.9% Sodium Chloride Injection, 4 mg per 250 mL (16 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-227-01.

by SterRx, LLC

Reason
Lack of Assurance of Sterility
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 6, 2023Historical recordClass II

Succinylcholine Chloride Injection, 200 mg per 10 mL (20 mg per mL), 1,000 mL, Rx only, SterRx, 141 Idaho Avenue, Plattsburgh, NY 12903, NDC 70324-826-01.

by SterRx, LLC

Reason
Lack of Assurance of Sterility
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 6, 2023Historical recordClass II

Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1000 mL (12.6 mg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-326-01.

by SterRx, LLC

Reason
Lack of Assurance of Sterility
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 6, 2023Historical recordClass II

PHENYLepherine HCL in 0.9% Sodium Chloride, 20 mg per 250 mL (80 mcg per mL), Rx only, SterRx, 141 Idaho Avenue, Plattsburgh, NY 12903, NDC 70324-701-01.

by SterRx, LLC

Reason
Lack of Assurance of Sterility
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 6, 2023Historical recordClass II

EPINEPHrine, 2 mg per 250 mL (8 mcg per mL) in 0.9% Sodium Chloride Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY, 12903, NDC 70324-027-01.

by SterRx, LLC

Reason
Lack of Assurance of Sterility
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 6, 2023Historical recordClass II

NOREPINEPHRINE 4 mg per 250 mL (16 mcg per mL) in 5% Dextrose Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-451-01.

by SterRx, LLC

Reason
Lack of Assurance of Sterility
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 6, 2023Historical recordClass II

dilTIAZem HCl 125 mg per 125 mL (1 mg per mL) in 0.7% Sodium Chloride Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY, 12903, NDC 70324-976-01.

by SterRx, LLC

Reason
Lack of Assurance of Sterility
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 6, 2023Historical recordClass II

Morphine Sulfate in 0.9% Sodium Chloride Injection, 100 mg per 100 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Avenue, Plattsburgh, NY, 12903, NDC 70324-427-02.

by SterRx, LLC

Reason
Lack of Assurance of Sterility
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 6, 2023Historical recordClass II

Midazolam in 0.9% Sodium Chloride Injection, 50 mg per 50 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Ave. Plattsburgh, NY 12003, NDC #70324-102-01.

by SterRx, LLC

Reason
Lack of Assurance of Sterility
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: July 25, 2022Historical recordClass I

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

by Gilead Sciences, Inc.

Reason
Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 16, 2024Historical recordClass II

Betamethasone Dipropionate Lotion USP, 0.05% (Augmented), 30 mL bottle, (29 g), Rx Only, Teligent Pharma Inc., Buena, NJ, 08310, NDC 52565-023-29

by Teligent Pharma, Inc.

Reason
Failed Stability Specifications: lot did not meet specification for the Active Pharmaceutical Ingredient (API) particle test, which was determined through routine stability testing
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-997-64

by Teligent Pharma, Inc.

Reason
Superpotent Drug: Minimally superpotent
Published
January 5, 2022
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass I

Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-997-64

by Teligent Pharma, Inc.

Reason
Superpotent Drug
Published
January 5, 2022
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.